Interactions between Xenobiotics and DME (XEOTIC)
|
Health or Environmental Toxicant(s) |
Acute Toxic Substance |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Cycloheximide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01268
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Acute Toxic Substance |
DME Modulation |
Cycloheximide inhibits the drug-metabolizing activity of DME TYMP |
[1] |
Formaldehyde |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01305
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Formaldehyde up-regulates the expression of DME TYMP |
[2], [3] |
Salinomycin |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO01467
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Acute Toxic Substance |
DME Modulation |
Salinomycin up-regulates the expression of DME TYMP |
[4] |
Natural Product(s), Extract(s) or Medicine(s) |
Natural Mixture |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Dust |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01284
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Natural Mixture |
DME Modulation |
Dust inhibits the expression of DME TYMP |
[5] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 8 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen inhibits the expression of DME TYMP |
[6] |
Aspirin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00213
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Aspirin inhibits the expression of DME TYMP |
[7] |
Calcitriol |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00184
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Calcitriol up-regulates the expression of DME TYMP |
[8] |
Cisplatin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00334
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cisplatin inhibits the expression of DME TYMP |
[9], [10] |
Cyclosporine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00241
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Cyclosporine up-regulates the expression of DME TYMP |
[11] |
Fluorouracil |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00037
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Fluorouracil inhibits the expression of DME TYMP |
[9] |
Mitomycin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00089
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Mitomycin inhibits the drug-metabolizing activity of DME TYMP |
[12] |
Testosterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00095
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Testosterone up-regulates the expression of DME TYMP |
[13] |
Drug in Phase 3 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Curcumin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00683
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Curcumin inhibits the drug-metabolizing activity of DME TYMP |
[14] |
Triclosan |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00560
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Triclosan up-regulates the expression of DME TYMP |
[15] |
Vitamin E |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00547
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 3 |
DME Modulation |
Vitamin E up-regulates the expression of DME TYMP |
[16] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the expression of DME TYMP |
[17] |
IPI-504 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00661
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
IPI-504 inhibits the drug-metabolizing activity of DME TYMP |
[18] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Tetradecanoylphorbol acetate |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00599
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
Tetradecanoylphorbol acetate induces the drug-metabolizing activity of DME TYMP |
[19] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
GSK-J4 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01324
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Patented Pharmaceutical Agent |
DME Modulation |
GSK-J4 inhibits the expression of DME TYMP |
[20] |
|
|
|
|
|
|